Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Detection of oedema on optical coherence tomography images using deep learning model trained on noisy clinical data

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Branch retinal vein occlusion precipitated by compression between a major retinal artery and underlying optic disc drusen

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Evolving Evidence in Idiopathic Intracranial Hypertension

    Research output: Contribution to journalEditorialResearchpeer-review

  4. Oxidative Stress in Optic Neuropathies

    Research output: Contribution to journalReviewResearchpeer-review

  • Alan N Baer
  • Mara McAdams DeMarco
  • Stephen C Shiboski
  • Mi Y Lam
  • Stephen Challacombe
  • Troy E Daniels
  • Yi Dong
  • John S Greenspan
  • Bruce W Kirkham
  • Hector E Lanfranchi
  • Morten Schiødt
  • Muthiah Srinivasan
  • Hisanori Umehara
  • Frederick B Vivino
  • Cristina F Vollenweider
  • Yan Zhao
  • Lindsey A Criswell
  • Caroline H Shiboski
  • Sjögren's International Collaborative Clinical Alliance (SICCA) Research Groups (Steffen Ellitsgaard Hamann, members)
View graph of relations

OBJECTIVE: To determine whether the Sjögren's syndrome B (SSB)-positive/Sjögren's syndrome A (SSA)-negative antibody profile is associated with key phenotypic features of SS.

METHODS: Among registrants in the Sjögren's International Collaborative Clinical Alliance (SICCA) with possible or established SS, we compared anti-SSA/anti-SSB reactivity profiles against concurrent phenotypic features. We fitted logistic regression models to explore the association between anti-SSA/anti-SSB reactivity profile and each key SS phenotypic feature, controlling for potential confounders.

RESULTS: Among 3297 participants, 2061 (63%) had negative anti-SSA/anti-SSB, 1162 (35%) had anti-SSA with or without anti-SSB, and 74 (2%) anti-SSB alone. Key SS phenotypic features were more prevalent and had measures indicative of greater disease activity in those participants with anti-SSA, either alone or with anti-SSB, than in those with anti-SSB alone or negative SSA/SSB serology. These between-group differences were highly significant and not explained by confounding by age, race/ethnicity or gender. Participants with anti-SSB alone were comparable to those with negative SSA/SSB serology in their association with these key phenotypic features. Among SICCA participants classified with SS on the basis of the American-European Consensus Group or American College of Rheumatology criteria, only 2% required the anti-SSB-alone test result to meet these criteria.

CONCLUSIONS: The presence of anti-SSB, without anti-SSA antibodies, had no significant association with SS phenotypic features, relative to seronegative participants. The solitary presence of anti-SSB antibodies does not provide any more support than negative serology for the diagnosis of SS. This serological profile should thus be interpreted cautiously in clinical practice and potentially eliminated from future classification criteria.

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Issue number8
Pages (from-to)1557-61
Number of pages5
Publication statusPublished - Aug 2015

ID: 46230710